COMPARISON OF THE EFFECTS OF INHALED MILRINONE WITH INHALED LEVOSIMENDAN IN PATIENTS WITH SEVERE PULMONARY HYPERTENSION UNDERGOING ELECTIVE MITRAL VALVE REPLACEMENT SURGERY
Phase 4
- Conditions
- Health Condition 1: - Health Condition 2: I059- Rheumatic mitral valve disease, unspecified
- Registration Number
- CTRI/2023/07/055760
- Lead Sponsor
- GIPMER,NEW DELHI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
PATIENTS WITH MITRAL VALVE DISEASE AND SEVERE PULMONARY HYPERTENSION UNDERGOING ELECTIVE MITRAL VALVE REPLACEMENT SURGERY
Exclusion Criteria
1.Patients with concurrent coronary artery disease
2.Patients with coexisting aortic valve disease
3.Patients in NYHA grade III/IV
4.Patients requiring pre-operative inotropic support,
5.Patient requiring emergency surgery
6.Patients with coexisting hepatic, renal or severe respiratory disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method